Central Nervous System

Strategic biometrics support for complex CNS clinical trials

There’s no standard path for CNS studies

Intego Clinical provides adaptive and dependable solutions for every stage of your CNS trial. Central nervous system (CNS) clinical trials are among the most complex in the industry. With neurological, cognitive, and behavioral endpoints that often defy traditional metrics, they require specialized expertise.

At Intego Clinical, we deliver flexible, high-quality biometrics services designed to meet the unique needs of CNS drug development. From study design to real-time data analytics, our experienced team supports your success with creative and compliant solutions.

Our team has supported CNS trials at every stage, from early-phase designs to large-scale global studies. We are particularly skilled in managing atypical endpoints and aligning data strategies with regulatory expectations.

Tackling the toughest challenges in CNS studies

CNS trials face challenges that can limit insight and increase risk. Measuring cognitive and behavioral outcomes, managing high placebo effects, and addressing inconclusive endpoints require a data-driven partner with the expertise to manage variability and deliver actionable results.

We specialize in:

Complicated endpoint analysis
Protocol development tailored for CNS complexities
Real-time data monitoring and reporting
Customized statistical programming and trial design
Global support for diverse neurological studies

Why Intego Clinical for CNS?

Intego Clinical is a trusted biometrics CRO known for consistent delivery, scientific rigor, and client-centered support. Our customized approach and dedication to quality help pharmaceutical and biotech companies move confidently through even the most unpredictable CNS trials.

Whether you need strategic input on trial design or full-service biometrics support, Intego Clinical delivers results that reflect your goals, uphold regulatory standards, and stay aligned with patient needs.